Gapping up
In reaction to strong earnings/guidance: NDSN +1.7%, MW +1.5%.
M&A news: UNS +29.7% (to be acquired by Fortis Utility Group for $60.25/share in cash).
Other news: GNVC +14.9% (discloses it expects an IND will be filed for CGF166 in January 2014), VASC +9.5% (receives shonin approvals to launch GuideLiner Catheter and SuperCross FT Microcatheter in Japan), PRTA +7.7% (Roche and Prothena enter into worldwide collaboration to co-develop and co-promote antibodies for treatment of Parkinson's Disease), ERJ +4.7% (American Airlines signs agreements with Bombardier and Embraer S.A. (ERJ) to purchase 90 new 76-seat regional jets), TCS +4.5% (still checking), FB +3.9% ( FB to replace WMB in the S&P 100; FB to replace TER in the S&P 500), LOGI +3.7% (still checking), ADS +2.6% ( S&P MidCap 400 constituents ADS and MHK to replace ANF and JDSU in the S&P 500; S&P SmallCap 600 constituents ODFL and BC to replace ACI and RGS in the S&P MidCap 400), FRO +2.5% (still checking), MHK +2.4% ( S&P MidCap 400 constituents ADS and MHK to replace ANF and JDSU in the S&P 500), KS +2.3% (announced two-for-one stock split), XLS +1.8% (announced plan to spin off a new publicly traded military and government services company; to supply composite components for Boeing (BA) 787 Dreamliner), GERN +1.3% (favorable mention on Mad Money), BSX +1.1% ( FDA Advisory Panel Votes favorably on the Boston Scientific WATCHMAN Left Atrial Appendage Closure Device ), CLNE +1.1% (customers ordered 70% more natural gas vehicles through the third quarter of 2013 as compared to the same period in 2012), NOK +0.9% (favorable mention on Mad Money), ANSS +0.8% (receives formal notice from the Joint Committee on Taxation that finalizes FY 2009 and 2010 tax return refund claims; co's Q4 EPS will be favorably impacted by ~ $11 mln, or $0.11 - $0.12 per share (), VLRS +0.8% ( reports Nov booked passenger rose 19% YoY ), TSPT +0.6% (announces that ISS proxy advisory services recommends 'AGAINST' all proposals).
Analyst comments: LUV +0.9% ( upgraded to Buy from Neutral at BofA/Merrill; tgt raised to $23), JCI +0.6% (upgraded to Overweight from Equal Weight at Barclays), IRBT +0.5% (iRobot upgraded to Neutral from Underweight at JPMorgan), XOM +0.4% (upgraded to Buy from Neutral at ISI Group), INTC +0.2% (upgraded to Neutral from Reduce at Nomura)
M&A news: UNS +29.7% (to be acquired by Fortis Utility Group for $60.25/share in cash).
Other news: GNVC +14.9% (discloses it expects an IND will be filed for CGF166 in January 2014), VASC +9.5% (receives shonin approvals to launch GuideLiner Catheter and SuperCross FT Microcatheter in Japan), PRTA +7.7% (Roche and Prothena enter into worldwide collaboration to co-develop and co-promote antibodies for treatment of Parkinson's Disease), ERJ +4.7% (American Airlines signs agreements with Bombardier and Embraer S.A. (ERJ) to purchase 90 new 76-seat regional jets), TCS +4.5% (still checking), FB +3.9% ( FB to replace WMB in the S&P 100; FB to replace TER in the S&P 500), LOGI +3.7% (still checking), ADS +2.6% ( S&P MidCap 400 constituents ADS and MHK to replace ANF and JDSU in the S&P 500; S&P SmallCap 600 constituents ODFL and BC to replace ACI and RGS in the S&P MidCap 400), FRO +2.5% (still checking), MHK +2.4% ( S&P MidCap 400 constituents ADS and MHK to replace ANF and JDSU in the S&P 500), KS +2.3% (announced two-for-one stock split), XLS +1.8% (announced plan to spin off a new publicly traded military and government services company; to supply composite components for Boeing (BA) 787 Dreamliner), GERN +1.3% (favorable mention on Mad Money), BSX +1.1% ( FDA Advisory Panel Votes favorably on the Boston Scientific WATCHMAN Left Atrial Appendage Closure Device ), CLNE +1.1% (customers ordered 70% more natural gas vehicles through the third quarter of 2013 as compared to the same period in 2012), NOK +0.9% (favorable mention on Mad Money), ANSS +0.8% (receives formal notice from the Joint Committee on Taxation that finalizes FY 2009 and 2010 tax return refund claims; co's Q4 EPS will be favorably impacted by ~ $11 mln, or $0.11 - $0.12 per share (), VLRS +0.8% ( reports Nov booked passenger rose 19% YoY ), TSPT +0.6% (announces that ISS proxy advisory services recommends 'AGAINST' all proposals).
Analyst comments: LUV +0.9% ( upgraded to Buy from Neutral at BofA/Merrill; tgt raised to $23), JCI +0.6% (upgraded to Overweight from Equal Weight at Barclays), IRBT +0.5% (iRobot upgraded to Neutral from Underweight at JPMorgan), XOM +0.4% (upgraded to Buy from Neutral at ISI Group), INTC +0.2% (upgraded to Neutral from Reduce at Nomura)